Outset Medical, Inc. (OM)

Market Cap	1.08B
Revenue (ttm)	118.29M
Net Income (ttm)	-170.04M
Shares Out	49.23M
EPS (ttm)	-3.51
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	117,036
Open	22.10
Previous Close	22.32
Day's Range	21.84 - 22.24
52-Week Range	11.41 - 30.55
Beta	1.48
Analysts	Strong Buy
Price Target	27.60 (+25.28%)
Earnings Date	Jul 31, 2023

About OM

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 15, 2020
• Employees: 518
• Stock Exchange: NASDAQ
• Ticker Symbol: OM

Financial Performance

In 2022, Outset Medical's revenue was $115.38 million, an increase of 12.45% compared to the previous year's $102.60 million. Losses were -$162.96 million, 23.5% more than in 2021.

Analyst Forecast

According to 5 analysts, the average rating for OM stock is "Strong Buy." The 12-month stock price forecast is $27.6, which is an increase of 25.28% from the latest price.

Price Target

$27.6

(25.28% upside)

Analyst Consensus: Strong Buy